X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (269) 269
animals (209) 209
mice (124) 124
humans (112) 112
biochemistry & molecular biology (82) 82
ascites (66) 66
female (60) 60
ascites cells (56) 56
cell biology (50) 50
male (42) 42
oncology (41) 41
rats (37) 37
tumor cells, cultured (36) 36
tumors (36) 36
hepatoma ascites-cells (34) 34
cell line (33) 33
ehrlich ascites cells (33) 33
ehrlich ascites-cells (33) 33
carcinoma, ehrlich tumor - metabolism (29) 29
kinetics (29) 29
neoplasm transplantation (24) 24
ascites-cells (23) 23
middle aged (22) 22
radiation effects (22) 22
krebs ascites-cells (21) 21
proteins (21) 21
ehrlich ascites cell (20) 20
animal cells (19) 19
cancer (19) 19
cells, cultured (18) 18
phosphorylation (18) 18
purification (18) 18
ascites - etiology (17) 17
nuclear proteins - metabolism (17) 17
ascites - pathology (16) 16
cell division (16) 16
cell line, tumor (16) 16
physiology (16) 16
ascites cell (15) 15
carcinoma, ehrlich tumor (15) 15
differentiation (15) 15
krebs ii ascites cells (15) 15
leukemia inhibitory factor (15) 15
molecular sequence data (15) 15
pharmacology & pharmacy (15) 15
polyacrylamide-gel electrophoresis (15) 15
research (15) 15
expression (14) 14
growth (14) 14
inhibition (14) 14
time factors (14) 14
cell membrane - metabolism (13) 13
interleukin-6 (13) 13
ovarian cancer (13) 13
protein (13) 13
adult (12) 12
amino acid sequence (12) 12
ascites - metabolism (12) 12
biophysics (12) 12
cytotoxicity (12) 12
hela cells (12) 12
in vitro techniques (12) 12
liver neoplasms (12) 12
mice, inbred balb c (12) 12
molecular-cloning (12) 12
rna (12) 12
thymidine - metabolism (12) 12
x radiation (12) 12
aged (11) 11
carcinoma, ehrlich tumor - pathology (11) 11
dna (11) 11
dna replication (11) 11
glycolysis (11) 11
landschutz ascites-cells (11) 11
old medline (11) 11
ovarian neoplasms - pathology (11) 11
tritium (11) 11
blotting, western (10) 10
dose-response relationship, drug (10) 10
replicon initiation (10) 10
signal transduction (10) 10
tumor-cells (10) 10
antineoplastic agents - pharmacology (9) 9
autoradiography (9) 9
base sequence (9) 9
biology (9) 9
cell division - drug effects (9) 9
ehrlich ascites tumor cells (9) 9
flow cytometry (9) 9
gene expression (9) 9
hypoxia (9) 9
identification (9) 9
immunohistochemistry (9) 9
irradiation (9) 9
localization (9) 9
metabolism (9) 9
microscopy, electron (9) 9
mitochondria (9) 9
molecular weight (9) 9
neoplasms, experimental (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Drug Targeting, ISSN 1061-186X, 01/2018, Volume 26, Issue 1, pp. 27 - 35
Multidrug resistance (MDR) is a serious obstacle in breast cancer patients which limits chemotherapeutic drugs application. Our previous study confirmed that... 
methotrexate | Breast cancer | MDR | NPM | resistance mechanism | DRUG-SENSITIVITY | CANCER CELLS | INCREASES | IDENTIFICATION | PATHWAY | HEPATOMA ASCITES-CELLS | AKT INHIBITORS | PHARMACOLOGY & PHARMACY | PROTEOMIC ANALYSIS | PROTEINS | EXPRESSION | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, pp. e46858 - e46858
Tumor cells in ascites are a major source of disease recurrence in ovarian cancer patients. In an attempt to identify and profile the population of ascites... 
EPITHELIAL-MESENCHYMAL TRANSITION | INITIATING CELLS | BREAST-CANCER | SURVIVAL | ADHESION-MOLECULE | OVEREXPRESSION | STEM-CELLS | METASTASIS | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | CARCINOMA | Epithelial Cells - drug effects | Humans | Middle Aged | Ovarian Neoplasms - pathology | Spheroids, Cellular - pathology | RNA, Messenger - metabolism | Ovarian Neoplasms - genetics | Neoplasm Metastasis | Tumor Microenvironment - genetics | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Ovarian Neoplasms - metabolism | Spheroids, Cellular - drug effects | Tumor Microenvironment - drug effects | Mesenchymal Stromal Cells - drug effects | RNA, Messenger - genetics | Mesenchymal Stromal Cells - metabolism | Epithelial Cells - pathology | Transcriptome - drug effects | Cell Separation - methods | Cisplatin - pharmacology | Cell Adhesion - drug effects | Drug Resistance, Neoplasm - genetics | Phenotype | Animals | Ascites - genetics | Survival Analysis | Aged | Biomarkers, Tumor - genetics | Mice | Mesenchymal Stromal Cells - pathology | Ascites - pathology | Antigens | Medical research | Relapse | RNA | Development and progression | Ovarian cancer | Diseases | Advertising executives | Analysis | Stem cells | Medicine, Experimental | Genetic aspects | Ascites | Health aspects | Cell culture | Cytokeratin | Populations | Ovarian carcinoma | Mesenchyme | Epithelial cells | Oct-4 protein | Cytology | Stem cell transplantation | Metastasis | Cancer therapies | E-cadherin | Cell adhesion molecules | Genotype & phenotype | Allografts | CD44 antigen | Surgery | Cell cycle | Cell adhesion | Fibroblasts | Purification | Tumor-infiltrating lymphocytes | Therapeutic applications | Tumor cells | Mortality | Gynecology | Stat3 protein | Breast cancer | Gene expression | Patients | Obstetrics | Spheroids | Gelatinase B | NAD | Chemotherapy | Womens health | Medical prognosis | Morphology | Ascites cells | Tumors | Cancer | Index Medicus
Journal Article
Cell Death and Disease, ISSN 2041-4889, 01/2018, Volume 9, Issue 4, pp. 419 - 10
As the major and preferred treatment for ovarian cancer ascites, chemotherapy can reduce or inhibit recurrent ascites (hereafter re-ascites); however, some... 
CANCER | PLATINUM DRUGS | CELL BIOLOGY | Tumor cells | Survivin | Drug resistance | Autophagy | Patients | Ovarian cancer | MDR1 protein | Chemotherapy | Cell activation | Cell death | Cell lines | P-Glycoprotein | Ascites | Phagocytosis | Ascites cells | Apoptosis
Journal Article
Journal Article
NUCLEAR MEDICINE AND BIOLOGY, ISSN 0969-8051, 01/2012, Volume 39, Issue 1, pp. 15 - 22
Introduction: The purpose of this study was to compare the therapeutic efficacy and biodistribution of the monoclonal antibody MX35 labeled with either Bi-213... 
NUDE-MICE | CARCINOMA ASCITES-CELLS | Radioimmunotherapy | MX35 | MYELOTOXICITY | TARGETED ALPHA-THERAPY | INTRAPERITONEAL RADIOIMMUNOTHERAPY | ASTATINE-211 | Astatine | PHARMACOKINETICS | alpha-Particle | ANTI-CD33 ANTIBODIES | Bismuth | PHASE-I | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AT-211-MX35 F(AB')
Journal Article
Journal Article
Cancer Cell International, ISSN 1475-2867, 12/2014, Volume 14, Issue 1, pp. 540 - 540
Background: Endometrial carcinoma is one of the most common gynecologic malignancies. Estrogen plays a critical role in its pathogenesis, but the underlying... 
Nucleophosmin 1(NPM1) | Estrogen receptor-α(ERα) | Endometrial carcinomas | Estrogen | PHOSPHORYLATION | RISK | ANTIBODY | PROLIFERATION | INDUCTION | BREAST-CANCER | NUCLEAR-MATRIX PROTEIN | NUMATRIN | ONCOLOGY | HEPATOMA ASCITES-CELLS | Estrogen receptor-alpha(ER alpha) | ASSOCIATION
Journal Article
Journal Article
Letters in Drug Design and Discovery, ISSN 1570-1808, 11/2015, Volume 12, Issue 10, pp. 787 - 801
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, pp. e70332 - e70332
NaPi2b, a sodium-dependent phosphate transporter, is highly expressed in ovarian carcinomas and is recognized by the murine monoclonal antibody MX35. The... 
COMPLEMENT | IMMUNOTHERAPY | CARCINOMA ASCITES-CELLS | MULTIDISCIPLINARY SCIENCES | RADIOIMMUNOTHERAPY | BINDING-SITE | MX35 | BIODISTRIBUTION | PHASE-I | EXPRESSION | EPITHELIAL OVARIAN-CANCER | Immunohistochemistry | Surface Plasmon Resonance | Sodium-Phosphate Cotransporter Proteins, Type IIb - immunology | Humans | Ovarian Neoplasms - pathology | Antibody-Dependent Cell Cytotoxicity - immunology | Complement System Proteins - immunology | Sodium-Phosphate Cotransporter Proteins, Type IIb - antagonists & inhibitors | Antibodies, Monoclonal, Humanized - genetics | Flow Cytometry | Antibody Specificity - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Female | Ovarian Neoplasms - drug therapy | Antibodies, Monoclonal - immunology | Cell Survival - drug effects | Antibodies, Monoclonal - pharmacology | Cell Survival - immunology | Protein Binding - immunology | Neoplasms - drug therapy | Animals | Neoplasms - immunology | Cell Line, Tumor | Mice | Kinetics | Antibodies, Monoclonal, Humanized - immunology | Antibody-Dependent Cell Cytotoxicity - drug effects | Neoplasms - pathology | Ovarian Neoplasms - immunology | Phosphates | Care and treatment | Analysis | Monoclonal antibodies | Health aspects | Biopharmaceutics | Cancer | Ovarian cancer | Biotechnology | Flow cytometry | Ovarian carcinoma | Toxicity | Syngeneic grafts | Lung | Clinical trials | Cytotoxicity | Assaying | Tissues | Cancer therapies | Proteins | 20th century | Sodium phosphate | Immunotherapy | Parameter robustness | Dihydrofolate reductase | Localization | Antibody-dependent cell-mediated cytotoxicity | Medical research | Antigens | Immunoglobulins | Kidneys | Phosphate transporter | Organs | Lung carcinoma | Glycosylation | Tumor cell lines | Cytometry | Dilution | Gene amplification | Sodium | Human performance | Cell lines | Surface plasmon resonance | Transporter | Kidney transplantation | Tumors | Index Medicus
Journal Article
Biomicrofluidics, ISSN 1932-1058, 07/2013, Volume 7, Issue 4, pp. 41301 - 41301
Journal Article